Singapore: Global Non-Small Cell Lung Cancer (NSCLC) treatment market value will increase from USD5.1 billion in 2013 to...
Singapore: Recent worries over antibiotics losing their effectiveness will only be exacerbated by the FDA's latest drug ...
Singapore: US drugmaker, Bristol-Myers Squibb co has said that it is seeking Japanese health regulators approval of its ...
Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This...
Singapore: Germany's translational drug discovery organization, Lead Discovery Center (LDC), has entered into a licence ...
Singapore: U.S. Food and Drug Administration (FDA) has accepted to review Supplemental New Drug Application (sNDA) for E...
Singapore: Eisai EMEA (Europe, Middle East, Africa, Russia and Oceania), the R&D division of the Japan-based company...
Genzyme, a Sanofi company, announced that the Ministry of Health, Labour and Welfare (MHLW) has granted marketing approv...
Singapore: GE Healthcare Life Sciences plans to open a technology and training laboratory in Turkey by mid-2015 targetti...
Singapore: Takeda Pharmaceutical has terminated the development program for orteronel (TAK-700) for prostate cancer foll...
New Delhi: Panacea Biotec entered into a strategic alliance for R&D and commercialization of drug delivery-based, ge...
Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Sh...
Singapore: Shanghai Pharmaceuticals has entered into a strategic framework cooperation agreement with Secondary Military...
Singapore: RUNX3, a gene that is intensively studied for its function as a tumour suppressor, is likely to be a key and ...
The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the fi...
Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...
Singapore: TB Alliance has started a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (X...
Singapore: US based oncology biotechnology company, Ignyta, has acquired four targeted oncology development programs fro...
